A study published in Diabetes Care has found that incretin-based therapies, including liraglutide and sitagliptin, may offer ...

They offer investors very different value propositions.

Using continuous glucose monitors, behavioural insights, and one of Europe’s most comprehensive datasets, the startup is ...

In 1999, the U.S. Food and Drug Administration approved continuous glucose monitoring (CGM), a medical device that uses a ...

The multi-billion dollar CGM market is expected to experience substantial, double-digit percentage growth over the next five ...

Market Size: The global wearable technology market was valued at USD 54.8 billion in 2020 and is projected to reach USD 183.2 ...

Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what’s next in the ...

Continuous glucose monitoring metrics may be able to predict future glycemic trajectories for children and adolescents with ...

See how continuous glucose monitors replace painful finger sticks, deliver real-time alerts, and help prevent dangerous highs ...

Wearable sensors that use microneedles to painlessly take samples at skin level could help personalize health care and enable ...

World Experiences Switching Patients to CGM Devices,' the experts explore the following question: 1. What is a patient case ...

Ketone detection translates chemical presence into measurable electrical signals using signal conversion, amplification, and ...